News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Frazier Life Sciences X, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
SC 13D/A
| Frazier Life Sciences X, L.P. reports a 15.3% stake in NewAmsterdam Pharma Company N.V. |
| 06/09/2023 |
SC 13D/A
| Frazier Life Sciences X, L.P. reports a 13.5% stake in NewAmsterdam Pharma Company N.V. |
| 05/03/2022 |
4
| Frazier Life Sciences X, L.P. (10% Owner) has filed a Form 4 on HilleVax, Inc.|
Txns:
| Converted 2,736,234 shares
@ $13.6, valued at
$37.2M
Bought 1,764,706 shares
@ $17, valued at
$30M
Converted 37,212,796 convertible notes
@ $13.6, valued at
$506.1M
|
|
| 04/28/2022 |
3
| Frazier Life Sciences X, L.P. (10% Owner) has filed a Form 3 on HilleVax, Inc. |
| 12/17/2020 |
3/A
| Topper James N (CEO) has filed a Form 3/A on Frazier Lifesciences Acquisition Corp |
| 12/11/2020 |
4
| Topper James N (CEO) has filed a Form 4 on Frazier Lifesciences Acquisition Corp|
Txns:
| Granted 501,000 shares
@ $10, valued at
$5M
Bought 1,000,000 shares
@ $10, valued at
$10M
Granted 167,000 warrants
@ $11.5, valued at
$1.9M
Granted 333,333 warrants
@ $11.5, valued at
$3.8M
|
|
| 12/08/2020 |
3
| Topper James N (CEO) has filed a Form 3 on Frazier Lifesciences Acquisition Corp |
|
|